2248. Changes in Lipid Profiles for Patients to Tenofovir Alafenamide (TAF)-Containing Regimens: Perspectives from a Military HIV-Positive Cohort
Evan Ewers(Alexander T. Augusta Military Medical Center), Anuradha Ganesan(Walter Reed National Military Medical Center), Ryan C. Maves(Naval Medical Center San Diego), Robert Deiss, Karl Kronmann(Naval Medical Center Portsmouth), Seung Won(Henry M. Jackson Foundation), Jason F. Okulicz(Gilead Sciences (United States)), Tomas Ferguson(Madigan Army Medical Center), Brian K. Agan(Henry M. Jackson Foundation), Timothy J. Whitman, Tahaniyat Lalani(Henry M. Jackson Foundation)
Cited by 3
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176